The Landscape of COVID-19 Research in the United States: a Cross-sectional Study of Randomized Trials Registered on ClinicalTrials.Gov

The Landscape of COVID-19 Research in the United States: a Cross-sectional Study of Randomized Trials Registered on ClinicalTrials.Gov

Importance: SARS-CoV-2 has infected over 200 million people worldwide, resulting in more than 4 million deaths. Randomized controlled trials are the single best tool to identify effective treatments against this novel pathogen. Objective: To describe the characteristics of randomized controlled tria...

Full description

Bibliographic Details
Main Authors: Campbell, K.R (Author), Dougan, M. (Author), Fralick, M. (Author), Moggridge, J. (Author), North, C.M (Author), Sacks, C.A (Author), Wolf, M. (Author)
Format: Article
Language:English
Published: Springer 2022
Subjects:
adult
aged
anticoagulant agent
antivirus agent
Article
artificial ventilation
chloroquine
controlled study
coronavirus disease 2019
COVID-19
Cross-Sectional Studies
cross-sectional study
dipeptidyl carboxypeptidase inhibitor
epidemiology
geographic distribution
human
Humans
hydroxychloroquine
immunomodulating agent
major clinical study
medical research
monoclonal antibody
mortality
oxygen
pandemic
Pandemics
phase 1 clinical trial (topic)
phase 2 clinical trial (topic)
phase 3 clinical trial (topic)
phase 4 clinical trial (topic)
polyclonal antibody
randomized controlled trial (topic)
Randomized Controlled Trials as Topic
risk factor
risk reduction
sample size
SARS-CoV-2
treatment outcome
Treatment Outcome
United States
Online Access:View Fulltext in Publisher

Internet

View Fulltext in Publisher

Similar Items